Impact of Multidisciplinary Integrated Rehabilitation on ICU-Acquired Weakness in Critically Ill Patients: A Prospective Cohort Study on Clinical Efficacy, Functional Recovery, and Correlation Analysis
Hongfei Wang, Yin LiBackground
ICU-acquired weakness (ICU-AW) affects 25%–65% of critically ill patients, prolonging ventilation and hospitalization, impairing quality of life, and increasing mortality.
Objective
To assess MIR's effect on ICU-AW, functional recovery, and links to clinical, inflammatory, and nutritional markers.
Methods
This prospective, nonrandomized controlled trial at a single center enrolled 237 ventilated ICU patients (July 2022–July 2025). Patients were divided into control (
Results
Baseline data matched except RASS and prealbumin. MIR group had lower ICU-AW incidence (RR = 0.18), shorter ventilation (9.3 vs. 15.3 days), ICU stay (14.6 vs. 21.4 days), and lower 90-day mortality (20.5% vs. 38.3%;
Conclusion
MIR lowers ICU-AW risk, cuts ventilation and hospital stay, reduces 90-day death rate, and aids muscle, balance, and diaphragm recovery. Inflammation/nutrition changes weakly correlate with functional gain.